Ferroglobe PLC Schedules Third Quarter 2025 Earnings Call for November 6, 2025

Ferroglobe PLC Schedules Third Quarter 2025 Earnings Call for November 6, 2025 GlobeNewswire October 21, 2025 LONDON, Oct. 21, 2025 (GLOBE NEWSWIRE) — Ferroglobe PLC (NASDAQ: GSM) announced today that it will issue third quarter 2025 financial results after the market closes on Wednesday, November 5, 2025, and will host the quarterly earnings call on […]

Onex to Announce Third Quarter 2025 Results on November 7, 2025

Onex to Announce Third Quarter 2025 Results on November 7, 2025 GlobeNewswire October 21, 2025 All amounts in U.S. dollars unless otherwise stated TORONTO, Oct. 21, 2025 (GLOBE NEWSWIRE) — Onex Corporation (TSX: ONEX) will release its results for the third quarter ended September 30, 2025 on November 7, 2025. A live broadcast of Onex'

Genius Group Title Sponsor of Coindesk’s Bitcoin Treasury Month, Awarding 100 Million Satoshis in Prize Money

Genius Group Title Sponsor of Coindesk's Bitcoin Treasury Month, Awarding 100 Million Satoshis in Prize Money GlobeNewswire October 21, 2025 SINGAPORE, Oct. 21, 2025 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that it is the Title Sponsor of Coindesk's Bitcoin

CEA Industries ($BNC) Crosses Half-Million BNB Milestone

CEA Industries ($BNC) Crosses Half-Million BNB Milestone GlobeNewswire October 21, 2025 Louisville, CO, Oct. 21, 2025 (GLOBE NEWSWIRE) — CEA Industries Inc. (Nasdaq: BNC) (“BNC” or the “Company”) today announced that it now holds a total of 500,000 BNB tokens, with an average acquisition cost of approximately $870 per BNB, representing a total invested amount

EagleNXT Debuts MicaSense RedEdge-P Triple: A Game-Changer for Precision Drone Imaging

EagleNXT Debuts MicaSense RedEdge-P Triple: A Game-Changer for Precision Drone Imaging GlobeNewswire October 21, 2025 Revolutionary triple sensor package delivers superspectral data for agriculture, geospatial, and environmental markets WICHITA, Kan., Oct. 21, 2025 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (dba, EagleNXT) (the “Company” or “EagleNXT”) (NYSE: UAVS), a leading provider of advanced drone and

PetVivo Holdings, Inc. Addresses Veterinary Industry’s GEN Z Problem With Breakthrough AI License Agreement

PetVivo Holdings, Inc. Addresses Veterinary Industry's GEN Z Problem With Breakthrough AI License Agreement GlobeNewswire October 21, 2025 MINNEAPOLIS, Oct. 21, 2025 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQX: PETV; OTCID PETVW), in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc., an emerging biomedical device company focused on the commercialization of groundbreaking medical products

SharpLink Reports Total ETH Holdings Rise to 859,853 as of October 19, 2025; Total ETH and Cash Holdings of $3.5 Billion

SharpLink Reports Total ETH Holdings Rise to 859,853 as of October 19, 2025; Total ETH and Cash Holdings of $3.5 Billion GlobeNewswire October 21, 2025 Minneapolis, MN, Oct. 21, 2025 (GLOBE NEWSWIRE) — SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”), one of the world's largest corporate holders of Ether (“ETH”) and prominent industry

Solenic Medical Announces Successful Use of Its AMF Technology Under FDA Compassionate Use Authorization

Solenic Medical Announces Successful Use of Its AMF Technology Under FDA Compassionate Use Authorization Company to Exhibit at American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting 2025 GlobeNewswire October 21, 2025 DALLAS, Oct. 21, 2025 (GLOBE NEWSWIRE) — Solenic Medical, a medical device company developing an innovative treatment for orthopedic implant infections, today

AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure

AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure GlobeNewswire October 21, 2025 Research Triangle Park, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) — First-in-human trial of investigational gene therapy AB-1002 designed to evaluate safety and preliminary efficacy in participants with New

Scroll to Top